Pandemic Flu Vaccine Clinical Trial Standards To Be Discussed By FDA Committee July 23
This article was originally published in The Pink Sheet Daily
Executive Summary
Regulatory standards for swine flu vaccine will be discussed by committee. Manufacturers want flexibility above all else. "Bird flu" approval may be one model.
You may also be interested in...
FDA Innovation And Integrity Will Be Goodman's Role Under Reorganization
FDA's Office of Chief Scientist will lose some specific responsibilities but gain a broader mission under a reorganization proposed by Commissioner Margaret Hamburg
Flu Vaccine Licensure Depends On Adjuvant; Fall Vaccination Campaign Likely
Efforts are under way to expedite H1N1 vaccine development for a potential voluntary vaccine campaign in the fall, but how registration of the vaccine is handled by FDA depends on whether or not an adjuvant is used
FDA Innovation And Integrity Will Be Goodman's Role Under Reorganization
FDA's Office of Chief Scientist will lose some specific responsibilities but gain a broader mission under a reorganization proposed by Commissioner Margaret Hamburg